Please review the following instructions carefully as you prepare your abstract.  

The body of the abstract is not to exceed 350 words, excluding title. Authors’ names and institutions are not be included in the title or abstract but are to be submitted elsewhere in the submission. 

Authors must identify which category is appropriate for your abstract.  The following abstract categories are acceptable for submission:

• Research (e.g., clinical trials, laboratory studies, translational studies, descriptive studies, qualitative studies)
• Quality Improvement Projects and Initiatives
• Clinical Practice (e.g., best clinical practice exemplar, case study, disease management, palliative care (non-research), survivorship (non-research), symptom management (non-research)
• Program Initiatives (e.g., workforce, infrastructure, workflow)

Projects must be completed – incomplete projects will not be accepted.  

Illustrations, tables or bullet points are NOT permitted in the abstract.

Research, Evidence-Based Projects, and Quality Initiative Abstracts must address each of the following areas:

• Purpose of the project
• Relevant background – why is this a problem? What does the literature tell us?
• Methods - what did you do to conduct the study/project?
• Data analysis – what statistical tests were used?
• Results – what are the data?
• Conclusions - what do the data reveal?
• Implications – how might these data be used to change practice or guide further research? 

Clinical Practice/Program Initiative Abstracts must address each of the following areas:

• Thorough description of the clinical presentation or situation
• Synthesis of relevant literature
• Description of intervention(s) provided
• Outcome of the intervention/situation
• Implications for practice (clinical/administrative)

Note:  Each abstract will be scored based on the quality and the extent that each of the above metrics were met. 

• Abstracts must be free from commercial bias; promotional abstracts will not be accepted.  Data from for-profit or industry sources are not permitted.
• Accepted abstracts will be presented as e-posters. Authors will be asked to record a 5-minute presentation of their poster. Posters will be available for viewing throughout the meeting.
• ALL authors of accepted abstracts will be required to complete a disclosure form as delineated on the abstract submission form. 

Please contact Sue Lentz at 206-794-7022 with any questions.

All abstracts must be submitted by 11:59 PM, PST July 1, 2021.  This is a firm deadline. NO extensions!